ARTICLE | Company News
Medy-Tox Inc., Q-Med deal
October 6, 2008 7:00 AM UTC
The partners ended a 2007 deal to use Medy-Tox's technology for producing botulium toxin to develop and commercialize biologics for aesthetic and therapeutic indications. Originally, Q-Med agreed to l...